Lonza to buy U.S. biologics site from Roche for $1.2B (OTCMKTS:LZAGF)
Swiss contract drug manufacturer Lonza (OTCPK:LZAGF) (OTCPK:LZAGY) has agreed to acquire a large-scale biologics manufacturing site in California from Roche (OTCQX:RHHBY) (OTCQX:RHHBF) for $1.2B in cash. The Genentech facility in Vacaville…
